— Know what they know.
Not Investment Advice

OMIC NASDAQ

Singular Genomics Systems, Inc.
1W: +0.3% 1M: +0.6% 3M: -8.6% 1Y: +26.1% 3Y: -91.4%
$20.01
Last traded 2025-02-21 — delisted
NASDAQ · Healthcare · Medical - Instruments & Supplies · $50.8M mcap · 2M float · 0.729% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$50.8M
52W Range5.34-23.41
Volume7,908
Avg Volume13,411
Beta1.83
Dividend
Analyst Ratings
2 Buy 2 Hold 1 Sell
Consensus Buy
Company Info
CEOAndrew Spaventa
Employees255
SectorHealthcare
IndustryMedical - Instruments & Supplies
IPO Date2021-05-27
10931 North Torrey Pines Road
La Jolla, CA 92037
US
858 333 7830
About Singular Genomics Systems, Inc.

Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. The company manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits. It also offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics, and proteomics in one integrated instrument providing a versatile multiomics solution. The company has partnerships with Agilent Technologies, Dovetail Genomics, Lexogen, New England Biolab, QIAGEN, Roche, Twist Bioscience, and Watchmaker Genomics to validate their library preparation kits on the G4, as well as the Broad Institute of MIT and Harvard to connect the G4 to Terra platform, a data platform. Singular Genomics Systems, Inc. was incorporated in 2016 and is headquartered in La Jolla, California.

Recent Insider Trades

NameTypeSharesPriceDate
TANG KEVIN D-Return 372,000 $20.00 2025-02-21
Spaventa Andrew D-Return 5,271 2025-02-21
Spaventa Andrew D-Return 42,881 $18.90 2025-02-21
Spaventa Andrew D-Return 85 $20.00 2025-02-21
Spaventa Andrew D-Return 15,555 $38.40 2025-02-21

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms